Search - tctmd.com

Displaying 1 - 20 of 53

Sort: Relevancy | Date

News Daily News

The Biggest News of 2018: TCTMD’s Top 10

Shelley Wood

December 31, 2018

News Features

Top News in Prevention: 2018

Michael O'Riordan

December 28, 2018

News Daily News

Aspirin Should Play Limited Role in Primary Prevention: Review

Michael O'Riordan

November 27, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Conference News AHA 2018

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

Shelley Wood

November 13, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Daily News

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

L.A. McKeown

October 18, 2018

News Daily News

Beta-blocker Use in Pregnancy Doesn’t Up Birth Defect Risk, Study Suggests

Caitlin E. Cox

October 15, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

Presentation TCT Abstracts Posters 2018

IMPACT: Improving coronary graft Patency with postoperative Aspirin and Clopidogrel versus Aspirin and Ticagrelor

Presenter: Gerard Devlin

September 25, 2018

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Todd Neale

September 24, 2018

Polymer-Free BioFreedom Stent as Safe as Orsiro, but Not as Effective

News Conference News TCT 2018

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Michael O'Riordan

September 22, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

News Daily News

Aspirin Falters Yet Again in Primary Prevention: ASPREE

Michael O'Riordan

September 17, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

Presentation ESC 2018

ASCEND Randomized placebo-controlled trial of aspirin

Presenter: Jane Armitage

August 27, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Conference News ESC 2018

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

Todd Neale

August 26, 2018

Advertisement

The Biggest News of 2018: TCTMD’s Top 10

Top News in Prevention: 2018

Aspirin Should Play Limited Role in Primary Prevention: Review

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

Beta-blocker Use in Pregnancy Doesn’t Up Birth Defect Risk, Study Suggests

TCTMD’s Top 10 Most Popular Stories for September 2018

IMPACT: Improving coronary graft Patency with postoperative Aspirin and Clopidogrel versus Aspirin and Ticagrelor

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Aspirin Falters Yet Again in Primary Prevention: ASPREE

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

TCTMD’s Top 10 Most Popular Stories for August 2018

ASCEND Randomized placebo-controlled trial of aspirin

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content